MONMOUTH JUNCTION, NJ–(Marketwired – June 18, 2014) – DiamiR, LLC, a molecular diagnostics company focused on the development and commercialization of innovative tests for detection and monitoring of neurodegenerative diseases and cancer based on analysis of organ-enriched microRNA biomarker pairs in plasma, announced today that the company’s CEO, Dr. Kira Sheinerman, will be presenting at the 2014 BIO International Convention in San Diego, CA.